Načítá se...
Part 1: Background, Methodology, and Clinical Adoption of Pharmacogenetics
Equivalent drug doses may lead to wide interpatient variability with regard to drug response, reflected by differences in drug activity and normal tissue toxicity. A major factor responsible for this variability is variation among patients in their genetic constitution. Genetic polymorphism may affe...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228225/ https://ncbi.nlm.nih.gov/pubmed/21632456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0258 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|